Somewhat Positive News Coverage Likely to Impact Intermolecular (IMI) Share Price

Headlines about Intermolecular (NASDAQ:IMI) have been trending somewhat positive on Friday, AlphaOne Sentiment reports. AlphaOne, a service of Accern, scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. AlphaOne ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Intermolecular earned a news impact score of 0.21 on AlphaOne’s scale. AlphaOne also gave news headlines about the semiconductor company an impact score of 66 out of 100, indicating that recent press coverage is likely to have an impact on the company’s share price in the next several days.

Insider Buying and Selling by Quarter for Intermolecular (NASDAQ:IMI)

Intermolecular (IMI) traded up 9.09% during trading on Friday, reaching $0.96. The company had a trading volume of 2,627 shares. The stock’s market capitalization is $47.58 million. The firm has a 50-day moving average of $0.88 and a 200-day moving average of $0.97. Intermolecular has a 1-year low of $0.78 and a 1-year high of $1.69.

Separately, Needham & Company LLC reaffirmed a “hold” rating on shares of Intermolecular in a report on Thursday, February 16th.

COPYRIGHT VIOLATION WARNING: This article was originally published by Markets Daily and is the sole property of of Markets Daily. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.themarketsdaily.com/2017/06/16/somewhat-positive-news-coverage-likely-to-impact-intermolecular-imi-share-price-updated.html.

Intermolecular Company Profile

Intermolecular, Inc provides thin film solutions. The Company’s high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems.

Receive News & Ratings for Intermolecular Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intermolecular Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply